NeueHealth (NYSE:NEUE – Get Free Report) is one of 14 public companies in the “Hospital & medical service plans” industry, but how does it weigh in compared to its competitors? We will compare NeueHealth to related companies based on the strength of its earnings, profitability, institutional ownership, analyst recommendations, valuation, risk and dividends.
Earnings and Valuation
This table compares NeueHealth and its competitors gross revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
NeueHealth | $1.16 billion | -$1.15 billion | -0.04 |
NeueHealth Competitors | $80.60 billion | $2.78 billion | 8.71 |
NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
NeueHealth Competitors | 94 | 1116 | 2552 | 98 | 2.69 |
NeueHealth presently has a consensus price target of $8.00, suggesting a potential upside of 35.36%. As a group, “Hospital & medical service plans” companies have a potential upside of 18.93%. Given NeueHealth’s higher probable upside, research analysts plainly believe NeueHealth is more favorable than its competitors.
Volatility and Risk
NeueHealth has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.95, indicating that their average stock price is 5% less volatile than the S&P 500.
Institutional & Insider Ownership
63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
NeueHealth | -71.23% | N/A | -1.21% |
NeueHealth Competitors | 0.04% | -1.59% | -0.04% |
Summary
NeueHealth competitors beat NeueHealth on 10 of the 13 factors compared.
About NeueHealth
NeueHealth, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.